Baker Bros Reveals New Stake in Aquinox Pharmaceuticals (AQXP)
In a new filing with the SEC, Julian Baker and Felix Baker’s Baker Bros. Advisors revealed new stake in Aquinox Pharmaceuticals Inc (NASDAQ:AQXP)....
Posts Tagged ‘Incyte Corp (INCY)’
Veolia Environnement SA (ADR) (VE), Incyte Corporation (INCY), Cliffs Natural Resources Inc (CLF): 3 Great Downgrades You Should Know About
Analyst downgrades are a dime a dozen. They often move stocks, but few are what I would consider good calls. Historically, analysts have a tendency to...
Incyte Corporation (INCY), Pfizer Inc. (PFE): This Biotech Has So Many Reasons to Be Liked
Earlier this month, I wrote an article explaining that I liked Incyte Corporation (NASDAQ:INCY) on the basis of the blockbuster potential of its only...
Biogen Idec Inc. (BIIB), Incyte Corporation (INCY): Should Novartis AG (ADR) (NVS) Shareholders Be Worried About This?
As an investor in the health care sector, it can sometimes feel like everything — and everyone — is out to get you. The ongoing threat of...
Incyte Corporation (INCY), Pacific Biosciences of California (PACB), Astex Pharmaceuticals, Inc. (ASTX): 3 Humongous Health-Care Stocks This Week
While the overall market muddled through the past five days, some stocks were on fire. Here are three health-care stocks experiencing humongous gains...
GTx, Inc. (GTXI), Novartis AG (ADR) (NVS): This Week in Biotech
With the SPDR S&P Biotech Index up 37% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into...
Medivation Inc (MDVN), Seattle Genetics, Inc. (SGEN) – Biotech Buyouts: Who’s Next?
There’s been plenty of buzz lately about the continuing saga of the possible buyout of Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) by Amgen, Inc. (...
Incyte Corporation (INCY), Gilead Sciences, Inc. (GILD): Pop-Worthy Data, Incyte, but Let’s See More
The phase 2 data that Incyte Corporation (NASDAQ:INCY) presented on Wednesday was downright stellar. For a subgroup of the patients, the hazard ratio...
MannKind Corporation (MNKD), Incyte Corporation (INCY): Will This Large Biotech Pop Experience Analyst Backlash?
While I do think it’s possible that MannKind Corporation (NASDAQ:MNKD)‘s inhaled insulin device, Afrezza, will be approved by the Food and...
Pfizer Inc. (PFE), Novartis AG (ADR) (NVS): Does Incyte Corporation (INCY) Deserve Its New Valuation?
One of the hottest stocks on the market Wednesday was Incyte Corporation (NASDAQ:INCY), a pharmaceutical company specializing in the development of JAK...
Novartis AG (ADR) (NVS): Why Incyte Corporation (INCY) Shares Skyrocketed
Although we don’t believe in timing the market or panicking over market movements, we do like to keep an eye on big changes — just in case...
Novartis AG (ADR) (NVS), Amgen, Inc. (AMGN): Incyte Corporation (INCY) Jumps on Jakafi Results
Incyte Corporation (NASDAQ:INCY) today announced positive results from a phase 2 study of its drug Jakafi in treating refractory metastatic pancreatic...
Incyte Corporation (INCY) Earnings Cruise on Jakafi Growth
Budding biotech company Incyte Corporation (NASDAQ:INCY), which specializes in developing novel JAK inhibitors, released solid second-quarter earnings...
Celgene Corporation (CELG), Alexion Pharmaceuticals, Inc. (ALXN): Is It Time To Invest In Mid & Small Cap Pharmaceuticals?
Having heard about and invested enough in large-cap pharma, I believe it is time to consider funding smaller firms in the sector. Below you will find...
Dendreon Corporation (DNDN), Bristol Myers Squibb Co. (BMY): Why Immunotherapy Stocks Could Be Set for a Big Move
If the JPMorgan Healthcare Conference in January is the mecca of all health-care events during the year, then the American Society of Clinical Oncology...
Will Pipeline Disasters Devour Eli Lilly & Co. (LLY) Stock?
Eli Lilly & Co. (NYSE:LLY) investors just can’t catch a break lately. This Big Pharma member had high hopes for replacing lost revenue from...
Pfizer Inc. (PFE): Risks, Hesitations & Key Opportunities
Take a look around the pharmaceutical industry and you won’t find many companies with market caps exceeding $100 billion (seven by my count). If...
Momenta Pharmaceuticals, Inc. (MNTA), Incyte Corporation (INCY), Solazyme Inc (SZYM): Three Biotech Companies for Young Investors
Take one look at the returns from biotech darlings Celgene Corporation (NASDAQ:CELG), Biogen Idec Inc. (NASDAQ:BIIB), and Gilead Sciences, Inc. (NASDAQ...
Why Cyprus Won’t Hold Back the Dow: JPMorgan Chase & Co. (JPM), Bank of America Corp (BAC), Incyte Corporation (INCY)
With the stock market near record highs, investors are on edge, and the slightest hint of trouble can cause near-panic. Given the news over the weekend...
Can Myriad Genetics, Inc. (MYGN) Survive the Supreme Court?
The market has been less than thrilled about an upcoming Supreme Court decision on the legality of the best-selling analytical test of Myriad Genetics...
Is Gilead Sciences, Inc. (GILD) Destined for Greatness?
Every investor can appreciate a stock that consistently beats the Street without getting ahead of its fundamentals and risking a meltdown. The best stocks...
Why Sanofi SA (NYSE:SNY) is Set for a Great 2013
Last year was a pretty good one for stockholders in Sanofi SA (NYSE:SNY), and the indications are that this year could be the same. It has been a difficult...
